Abstract

Primary Aldosteronism (PA)

is commonly considered in the diagnosis of a patient with hypokalemia or difficult to control hypertension. Clinical manifestations of PA are highly variable and serious hypertensive urgencies and emergencies are said to be rare. We performed a retrospective analysis of patients diagnosed with PA to identify clinical or biochemical features that would be predictive of a hypertensive emergency or urgency. Fifty-three patients who were evaluated from 1996 through 2002 at the University of Connecticut Health Center were included in this analysis. Patients included had a confirmed diagnosis of PA including a sodium suppression study and appropriate anatomic localization. They were classified as group I (resistant hypertension) and group II (hypertensive emergency based on the initial presentation or absolute blood pressure). A hypertensive emergency/urgency was defined as persistent BP > 200/100 mmHg or acute target organ damage such as pulmonary edema, cerebrovascular accident / transient ischemic attack, myocardial ischemia/infarction or acute renal failure. A comparison of the biochemical and clinical features in the two groups is shown below.

Using a linear regression model to predict Systolic BP and entering age, gender, serum aldosterone, aldosterone:renin ratio and BMI as predictor variables resulted in no significant predictors. No single biochemical or clinical feature was found to be predictive of a presentation as a hypertensive emergency/urgency and all patients with such a presentation need to be screened for primary aldosteronism. (See Table)

Clinical and Biochemical Features of 2 Presentations of PA

ParameterGroup 1Group 2P Value
Number3221
Age, years58 ± 1359 ± 16.76
BMI, kg/m230 ± 631 ± 8.4.56
Gender, F:M15:178:13.52
Potassium, mEq/L3.6 ± 0.633.7 ± 0.63.8
Creatinine, mg/dL1.0 ± 0.31.2 ± 0.4.11
Aldosterone, ng/dL22 ± 726 ± 16.3
Aldosterone (ng/dL): Plasma Renin Activity (ng/mL/h)11–38811–289.66
Systolic Blood Pressure, mmHg172 ± 28208 ± 7.001
ParameterGroup 1Group 2P Value
Number3221
Age, years58 ± 1359 ± 16.76
BMI, kg/m230 ± 631 ± 8.4.56
Gender, F:M15:178:13.52
Potassium, mEq/L3.6 ± 0.633.7 ± 0.63.8
Creatinine, mg/dL1.0 ± 0.31.2 ± 0.4.11
Aldosterone, ng/dL22 ± 726 ± 16.3
Aldosterone (ng/dL): Plasma Renin Activity (ng/mL/h)11–38811–289.66
Systolic Blood Pressure, mmHg172 ± 28208 ± 7.001

Clinical and Biochemical Features of 2 Presentations of PA

ParameterGroup 1Group 2P Value
Number3221
Age, years58 ± 1359 ± 16.76
BMI, kg/m230 ± 631 ± 8.4.56
Gender, F:M15:178:13.52
Potassium, mEq/L3.6 ± 0.633.7 ± 0.63.8
Creatinine, mg/dL1.0 ± 0.31.2 ± 0.4.11
Aldosterone, ng/dL22 ± 726 ± 16.3
Aldosterone (ng/dL): Plasma Renin Activity (ng/mL/h)11–38811–289.66
Systolic Blood Pressure, mmHg172 ± 28208 ± 7.001
ParameterGroup 1Group 2P Value
Number3221
Age, years58 ± 1359 ± 16.76
BMI, kg/m230 ± 631 ± 8.4.56
Gender, F:M15:178:13.52
Potassium, mEq/L3.6 ± 0.633.7 ± 0.63.8
Creatinine, mg/dL1.0 ± 0.31.2 ± 0.4.11
Aldosterone, ng/dL22 ± 726 ± 16.3
Aldosterone (ng/dL): Plasma Renin Activity (ng/mL/h)11–38811–289.66
Systolic Blood Pressure, mmHg172 ± 28208 ± 7.001
This content is only available as a PDF.
You do not currently have access to this article.